Sector Leaders Briefing & Capital Raise News: Muscle Warfare, Baidu, Herblife, Gilead Sciences and ARIAD

Sector Leaders Briefing & Capital Raise News: Muscle Warfare, Baidu, Herblife,
                          Gilead Sciences and ARIAD

PR Newswire

CORAL SPRINGS, Florida, October 30, 2013

CORAL SPRINGS, Florida, October 30, 2013 /PRNewswire/ --

Market news commentary and reports for sector leading nutrition, technology &
pharma companies: Muscle Warfare International Inc. (OTC: MWAR), Baidu Inc
(NASDAQ: BIDU), Herbalife Ltd. (NYSE: HLF), Gilead Sciences, Inc. (NASDAQ:
GILD) and ARIAD Pharmaceuticals, Inc.(NASDAQ: ARIA).

Muscle Warfare International Inc. (OTC: MWAR) releases investor information
for 506 Capital Raise - Muscle Warfare International releases power point
presentation for investors that are interested with the companies 506 private
placement memorandum. MWAR is in the process of raising $2,000,000
(two-million dollars), interested investors may look at our power point on the
OTC Market and can call Freebird USA regarding the PPM or to obtain any
questions they may have. 

On September 23, the JOBS Act-mandated SEC rule permitting general
solicitation and advertising of private offerings conducted under SEC Rules
506(c) and Rule 144A went into effect, opening a key door to capital for U.S.
and global companies. Lifting the ban on transparency in private offerings
will also aid in producing more efficient pricing for private and
publicly-traded companies, as investors will be able to price in the
performance of a private offering into a company's valuation. It could create
a standard for more companies to share information in the public markets,
creating a virtuous circle for issuers and investors. Companies that are
providing insight into their business operations and financials for the first
time may be inclined to continue providing ongoing news and disclosure,
whether on their website or through a public disclosure service like OTC
Markets Group's OTC Disclosure & News Service"

Read the full release at

Accredited Investor - While general solicitation of Rule 506(c) offerings is
now permitted, purchasers in a Rule 506(c) offering must be "accredited
investors." The SEC defines the term "accredited investor" in Rule 501(a).
Generally, individuals are considered accredited investors if they have a net
worth greater than $1 million (excluding their primary residence) or incomes
in excess of $200,000 in the last two years with the expectation of the same
in the current year (or $300,000 with a spouse). 

Muscle Warfare International, Inc CEO Daniel Amato stated, "Our new initiative
to raise funds through a PPM is very exciting and we look forward to
partnering with new investors. MWAR is raising the capital so, that we may
proceed to the next step of our business plan and continue to market our
company, attend trade shows and hire new staff. Also, with the funds it allows
us the opportunity to hire more staff to assist some of Muscle Warfare clients
such as GNC, Inc. (NYSE: GNC), Vitamin Shoppe, Inc. (NYSE: VSI), Europa Sports
Products, Fitness First USA and many others.

Chinese Internet company Baidu Inc (NASDAQ: BIDU) said it experienced strong
growth in mobile search revenue during the third quarter and forecast
better-than-expected revenue for the final three months of the year. Shares
of Baidu were up 5.6 percent to $168.30 in after hours trading on Tuesday
(10/29/13) - Baidu, the largest Internet search engine in China, projected
that revenue in the fourth quarter will range between 9.220 billion yuan and
9.480 billion yuan. Analysts polled by Thomson Reuters I/B/E/S were looking
for Q4 revenue of 8.904 yuan. Baidu's net income saw a slight bump in the
third quarter, rising 1.3 percent to 3.048 billion yuan. Read the full
release at

Herbalife Ltd. (NYSE: HLF) reported third quarter net sales of $1.2 billion,
reflecting an increase of 19 percent compared to the same time period in 2012
on volume point growth of 13 percent. Adjusted1 net income for the quarter of
$152.1 million, or $1.41 per diluted share, compares to the third quarter 2012
net income of $111.9 million and EPS of $0.98, respectively. On an as reported
basis, third quarter 2013 EPS of $1.32 increased 35 percent compared to the
$0.98 reported in the comparable quarter last year. To read the full report
please go to

Gilead Sciences, Inc. (NASDAQ: GILD) announced its results of operations for
the quarter ended September 30, 2013. Total revenues for the third quarter of
2013 increased 15 percent to $2.78 billion, from $2.43 billion for the third
quarter of 2012. Product sales increased 15 percent to $2.71 billion for the
third quarter of 2013 compared to $2.36 billion for the third quarter of 2012.
Net income for the third quarter of 2013 was $788.6 million, or $0.47 per
diluted share compared to $675.5 million, or $0.43 per diluted share for the
third quarter of 2012. Non-GAAP net income for the third quarter of 2013,
which excludes acquisition-related, restructuring and stock-based compensation
expenses, was $879.1 million, or $0.52 per diluted share compared to $788.9
million, or $0.50 per diluted share for the third quarter of 2012.  Read the
full report at

ARIAD Pharmaceuticals, Inc.(NASDAQ: ARIA), an oncology company, focuses on the
discovery, development, and commercialization of medicines for cancer
patients. The company focuses on commercializing Iclusig (ponatinib), a cancer
medicine; and developing additional molecularly targeted therapies to treat
patients with blood cancers and solid tumors. ARIA was up almost 4% in after
hours trading on Tuesday (10/29/2013) after closing down on 13.9Million shares
traded by market close. is leading provider of third party publishing &news
dissemination services. If you would like more information regarding our news
coverage solutions, please visit for more
details. Get an edge on the market with ourPremium News Alerts that are
FREE for a limited time at Follow us on
Facebook: and

DISCLAIMER: FN Media Group LLC (FNMG) is a third party publisher and news
dissemination service provider, which disseminates electronic information
through multiple online media channels. FNMG is NOT affiliated in any manner
with any company mentioned herein. FNMG and its affiliated companies are a
news dissemination and financial marketing solutions provider and are NOT a
registered broker/dealer/analyst/adviser, holds no investment licenses and may
NOT sell, offer to sell or offer to buy any security. FNMG's market updates,
news alerts and corporate profiles are NOT a solicitation or recommendation to
buy, sell or hold securities. The material in this release is intended to be
strictly informational and is NEVER to be construed or interpreted as research
material. All readers are strongly urged to perform research and due
diligence on their own and consult a licensed financial professional before
considering any level of investing in stocks. The companies that are
discussed in this release may or may not have approved the statements made in
this release. FNMG is not liable for any investment decisions by its readers
or subscribers. Investors are cautioned that they may lose all or a portion
of their investment when investing in stocks. FNMG was compensated one
thousand two hundred fifty dollars for the dissemination of this news release
by Muscle Warfare International Inc. (OTC: MWAR).


This release contains "forward-looking statements" within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E the
Securities Exchange Act of 1934, as amended and such forward-looking
statements are made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995. "Forward-looking statements"
describe future expectations, plans, results, or strategies and are generally
preceded by words such as "may", "future", "plan" or "planned", "will" or
"should", "expected," "anticipates", "draft", "eventually" or "projected". You
are cautioned that such statements are subject to a multitude of risks and
uncertainties that could cause future circumstances, events, or results to
differ materially from those projected in the forward-looking statements,
including the risks that actual results may differ materially from those
projected in the forward-looking statements as a result of various factors,
and other risks identified in a company's annual report on Form 10-K or 10-KSB
and other filings made by such company with the Securities and Exchange
Commission. You should consider these factors in evaluating the
forward-looking statements included herein, and not place undue reliance on
such statements. The forward-looking statements in this release are made as of
the date hereof and FNMG undertakes no obligation to update such statements.

Contact Information:
Company: FN Media Group, LLC
Contact email:
U.S. Phone: +1-954-345-0611

SOURCE FN Media Group, LLC
Press spacebar to pause and continue. Press esc to stop.